Occudo Quantitative Strategies LP Acquires New Stake in Intuitive Surgical, Inc. $ISRG

Occudo Quantitative Strategies LP bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, HoldingsChannel.com reports. The fund bought 6,392 shares of the medical equipment provider’s stock, valued at approximately $3,473,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Norway Savings Bank grew its position in shares of Intuitive Surgical by 53.4% in the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after buying an additional 910 shares during the last quarter. Trust Co. of Oklahoma acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $363,000. IronOak Wealth LLC. purchased a new position in Intuitive Surgical in the second quarter worth $1,099,000. Eastover Investment Advisors LLC increased its position in shares of Intuitive Surgical by 204.8% during the second quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock worth $7,153,000 after purchasing an additional 8,844 shares in the last quarter. Finally, Amalgamated Bank lifted its holdings in shares of Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after purchasing an additional 1,772 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Down 1.5%

Shares of NASDAQ ISRG opened at $547.36 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business’s 50 day moving average price is $527.82 and its 200 day moving average price is $505.98. The firm has a market cap of $196.22 billion, a P/E ratio of 72.40, a P/E/G ratio of 5.11 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the previous year, the business posted $1.84 EPS. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the completion of the transaction, the executive vice president directly owned 5,758 shares of the company’s stock, valued at approximately $3,310,850. The trade was a 37.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 104 shares of the company’s stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $559.90, for a total value of $58,229.60. The disclosure for this sale is available in the SEC filing. Insiders sold 109,043 shares of company stock valued at $60,816,225 in the last 90 days. 0.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several brokerages recently issued reports on ISRG. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Evercore ISI upped their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Raymond James Financial set a $603.00 target price on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Rothschild & Co Redburn boosted their target price on shares of Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Finally, Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $606.54.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.